TRIANA Trademark

Trademark Overview


On Tuesday, February 22, 2022, a trademark application was filed for TRIANA with the United States Patent and Trademark Office. The USPTO has given the TRIANA trademark a serial number of 97278191. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, January 31, 2024. This trademark is owned by Triana Biomedicines, Inc.. The TRIANA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases

research and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
triana

General Information


Serial Number97278191
Word MarkTRIANA
Filing DateTuesday, February 22, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, January 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
Goods and Servicesresearch and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 28, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTriana Biomedicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameTriana Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Friday, February 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 31, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 31, 2024SOU EXTENSION 1 FILED
Wednesday, January 31, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 31, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 31, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 13, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2022ASSIGNED TO EXAMINER
Monday, February 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 25, 2022NEW APPLICATION ENTERED